Skip to main content

Want a detailed portfolio tracker?

Poseida Therapeutics (PSTX) Free Cash Flow (2020 - 2024)

Poseida Therapeutics (PSTX) free cash flow from Sep 30, 2020 to Sep 30, 2024. The TTM Poseida Therapeutics (PSTX) free cash flow is -$17M. You can adjust inflation or export chart.

Annual Free Cash Flow

Quarterly Free Cash Flow

Poseida Therapeutics (PSTX) Free Cash Flow CAGR table

PeriodCAGR
1 Year TTM-73.28%
3 Years TTM-51.05%
All Time TTM-51.04%

Annual Free Cash Flow change of Poseida Therapeutics (PSTX)

YearFree Cash FlowChange
2024$12M-112.54%
2023-$95M+210.33%
2022-$31M-70.82%
2021-$105M-19.25%
2020-$130MN/A